Skip to content
10-K

Annual Report

HUMAN GENOME SCIENCES INC

0001193125-12-085140

← back to feed
Filed
Feb 28, 2012 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Jan 31, 2012 198.98M sh
Shares Diluted FY 2011 · Dec 31, 2011 193.67M sh
Shares Diluted FY 2011 · Dec 31, 2010 187.79M sh
Shares Diluted FY 2011 · Dec 31, 2009 155.05M sh
Stock Repurchased FY 2011 · Dec 31, 2011 $1.04M
Stock Repurchased FY 2011 · Dec 31, 2010 $1.03M
Stock Repurchased FY 2011 · Dec 31, 2009 $15K
Capex FY 2011 · Dec 31, 2011 $18.99M
Capex FY 2011 · Dec 31, 2010 $9.78M
Capex FY 2011 · Dec 31, 2009 $10.02M
Operating Cash Flow FY 2011 · Dec 31, 2011 −$397.92M
Operating Cash Flow FY 2011 · Dec 31, 2010 −$280.69M
Operating Cash Flow FY 2011 · Dec 31, 2009 −$332K
Long Term Debt FY 2011 · Dec 31, 2011 $615.8M
Long Term Debt FY 2011 · Dec 31, 2010 $434.75M
Short Term Debt FY 2011 · Dec 31, 2011 $198.04M
Short Term Debt FY 2011 · Dec 31, 2010 $188.62M
Cash And Equivalents FY 2011 · Dec 31, 2011 $402.05M
Cash And Equivalents FY 2011 · Dec 31, 2010 $155.69M
Cash And Equivalents FY 2011 · Dec 31, 2009 $567.67M
Cash And Equivalents FY 2011 · Dec 31, 2008 $15.25M
Stockholders Equity FY 2011 · Dec 31, 2011 $456.42M
Stockholders Equity FY 2011 · Dec 31, 2010 $585.76M
Stockholders Equity FY 2011 · Dec 31, 2009 $755.42M
Stockholders Equity FY 2011 · Dec 31, 2008 −$136.3M
Current Liabilities FY 2011 · Dec 31, 2011 $323.55M
Current Liabilities FY 2011 · Dec 31, 2010 $280.94M
Total Liabilities FY 2011 · Dec 31, 2011 $951.16M
Total Liabilities FY 2011 · Dec 31, 2010 $729.27M
Current Assets FY 2011 · Dec 31, 2011 $650.1M
Current Assets FY 2011 · Dec 31, 2010 $531.18M
Total Assets FY 2011 · Dec 31, 2011 $1.41B
Total Assets FY 2011 · Dec 31, 2010 $1.32B
Rd Expense FY 2011 · Dec 31, 2011 $196.18M
Rd Expense FY 2011 · Dec 31, 2010 $196.37M
Rd Expense FY 2011 · Dec 31, 2009 $173.71M
Net Income FY 2011 · Dec 31, 2011 −$81.02M
Net Income FY 2011 · Dec 31, 2011 −$381.11M
Net Income FY 2011 · Sep 30, 2011 −$88.43M
Net Income FY 2011 · Jun 30, 2011 −$80.66M
Net Income FY 2011 · Mar 31, 2011 −$131M
Net Income FY 2011 · Dec 31, 2010 −$87.63M
Net Income FY 2011 · Dec 31, 2010 −$233.23M
Net Income FY 2011 · Sep 30, 2010 −$40.86M
Net Income FY 2011 · Jun 30, 2010 −$56.86M
Net Income FY 2011 · Mar 31, 2010 −$47.88M
Net Income FY 2011 · Dec 31, 2009 $5.66M
Operating Income FY 2011 · Dec 31, 2011 −$69.06M
Operating Income FY 2011 · Dec 31, 2011 −$329.55M
Operating Income FY 2011 · Sep 30, 2011 −$76M
Operating Income FY 2011 · Jun 30, 2011 −$68.49M
Operating Income FY 2011 · Mar 31, 2011 −$116M
Operating Income FY 2011 · Dec 31, 2010 −$76.18M
Operating Income FY 2011 · Dec 31, 2010 −$190.77M
Operating Income FY 2011 · Sep 30, 2010 −$29.83M
Operating Income FY 2011 · Jun 30, 2010 −$46.99M
Operating Income FY 2011 · Mar 31, 2010 −$37.77M
Operating Income FY 2011 · Dec 31, 2009 $6.19M
Cost Of Revenue FY 2011 · Dec 31, 2011 $47.06M
Cost Of Revenue FY 2011 · Dec 31, 2010 $29.94M
Cost Of Revenue FY 2011 · Dec 31, 2009 $15.81M
Revenue FY 2011 · Dec 31, 2011 $45.52M
Revenue FY 2011 · Dec 31, 2011 $130.98M
Revenue FY 2011 · Sep 30, 2011 $34.02M
Revenue FY 2011 · Jun 30, 2011 $24.86M
Revenue FY 2011 · Mar 31, 2011 $26.57M
Revenue FY 2011 · Dec 31, 2010 $21.26M
Revenue FY 2011 · Dec 31, 2010 $157.35M
Revenue FY 2011 · Sep 30, 2010 $50.78M
Revenue FY 2011 · Jun 30, 2010 $38.79M
Revenue FY 2011 · Mar 31, 2010 $46.51M
Revenue FY 2011 · Dec 31, 2009 $275.75M
Stock Issued FY 2011 · Dec 31, 2009 17.83M sh
Stock Issued FY 2011 · Aug 31, 2009 26.7M sh